In clinical trials, Imaavy plus standard therapy improved muscle strength and daily function in adults and adolescents with generalized myasthenia gravis.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/ema-backs-first-fcrn-inhibitor-myasthenia-gravis-2025a1000p7b?src=rss
Author :
Publish date : 2025-09-22 15:29:00
Copyright for syndicated content belongs to the linked Source.
